Isabel Cuenca
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression.
Journal: Blood cancer journal
Published: November 09, 2023
Identification of Immunoglobulin Gene Rearrangement Biomarkers in Multiple Myeloma through cfDNA-Based Liquid Biopsy Using tchDNA-Seq.
Journal: Cancers
Published: April 19, 2023
NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial.
Journal: Cancers
Published: September 16, 2022
CNL and aCML should be considered as a single entity based on molecular profiles and outcomes.
Journal: Blood advances
Published: May 26, 2022
Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis.
Journal: Leukemia
Published: November 19, 2019
Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients.
Journal: Blood cancer journal
Published: September 04, 2019
Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing.
Journal: Haematologica
Published: June 30, 2018
Spectrum and functional validation of PSMB5 mutations in multiple myeloma.
Journal: Leukemia
Published: May 08, 2018
Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma.
Journal: Leukemia
Published: February 18, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026